Reported 3 days ago
WellTheory, a health tech startup focused on enhancing autoimmune care through artificial intelligence, has raised $14 million in Series A funding, led by General Catalyst and featuring contributions from female-led venture capitalists. Founded by Ellen Rudolph, the company aims to address the organic causes of autoimmune symptoms with personalized treatment plans. With over 50 million Americans affected by autoimmune diseases, WellTheory's funding will enable broader partnerships and further development of its AI-driven platform, featuring personalized care teams to improve patient experiences.
Source: YAHOO